Despite lower revenue, Zumiez's P/S ratio aligns with the industry, hinting at overlooked limited growth expectations. The weaker revenue outlook could lead to a share price and P/S ratio drop. A positive shift is needed to justify the current P/S ratio.
The company's CEO, Rick Brooks, stated that they are reviewing cost-saving strategies which could include closing underperforming stores and reducing labor costs. Despite the downbeat outlook, the company expects to open 10 new stores.
The three-year loss experienced by shareholders may indicate unresolved business challenges. This long-term share price weakness is generally considered a bad sign. However, some contrarian investors might research the stock in hope of a turnaround.
Ark Invest buys more Coinbase shares amid SEC crackdown Cathie Wood's Ark Invest boosted its holdings in$Coinbase (COIN.US)$amidst a crypto industry crackdown by the SEC, driving the stock to nearly five-month lows. Data from Cathie's Ark revealed that three of Wood's funds purchased over 400,000 Coinbase shares, with her main$ARK Innovation ETF (ARKK.US)$acquiring more than 300,000. This occurred as Coinbase's stock pri...
Gapping up $DocuSign (DOCU.US)$+16% (fiscal second-quarter earnings and revenue that topped Wall Street estimates and raised its forecast for fiscal-year billings.) $Zscaler (ZS.US)$+15% (the internet security platform issued a forecast better than Wall Street estimates.) $Tesla (TSLA.US)$+1.3% (The electric vehicle maker is considering building a lithium refinery for EV battery production in Texas this year, according to an applicati...
$Zumiez (ZUMZ.US)$Even after accounting for negative growth for the next 5 years, and lower margins, on my most conservative estimates this stock should be at least 2x in the coming years.
Gainers: •$Okta (OKTA.US)$+15.8% (In reaction to earnings) •$StoneCo (STNE.US)$+12.9% (In reaction to earnings) •$Turning Point Therapeutics (TPTX.US)$+116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025) •$Amylyx Pharmaceuticals (AMLX.US)$+24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
$Zumiez (ZUMZ.US)$shares rose 1% in premarket trading after the streetwear and sports apparel company announced a $150 million stock buyback program.
1
Report
No comment yet
- No more -
Sign in to post a comment
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Zumiez Stock Forum
Zumiez Q3 Net Income USD 1.159 Million Vs. IBES Estimate USD 440 Thousand
Cathie Wood's Ark Invest boosted its holdings in $Coinbase (COIN.US)$ amidst a crypto industry crackdown by the SEC, driving the stock to nearly five-month lows. Data from Cathie's Ark revealed that three of Wood's funds purchased over 400,000 Coinbase shares, with her main $ARK Innovation ETF (ARKK.US)$ acquiring more than 300,000. This occurred as Coinbase's stock pri...
$DocuSign (DOCU.US)$ +16% (fiscal second-quarter earnings and revenue that topped Wall Street estimates and raised its forecast for fiscal-year billings.)
$Zscaler (ZS.US)$ +15% (the internet security platform issued a forecast better than Wall Street estimates.)
$Tesla (TSLA.US)$ +1.3% (The electric vehicle maker is considering building a lithium refinery for EV battery production in Texas this year, according to an applicati...
• $Okta (OKTA.US)$ +15.8% (In reaction to earnings)
• $StoneCo (STNE.US)$ +12.9% (In reaction to earnings)
• $Turning Point Therapeutics (TPTX.US)$ +116.8% (Bristol Myers Squibb (BMY) will acquire Turning Point Therapeutics for $76,00 per share; expected to be accretive to Non-GAAP earnings per share beginningin2025)
• $Amylyx Pharmaceuticals (AMLX.US)$ +24.9% (receives PDUFA date extension for AMX0035; scheduled for September ...
No comment yet